We are live on ! Find out more
BLFS icon

BioLife Solutions

80 hedge funds and large institutions have $170M invested in BioLife Solutions in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

33% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 21

13% more capital invested

Capital invested by funds: $150M → $170M (+$19.9M)

10% more funds holding

Funds holding: 7380 (+7)

2.59% more ownership

Funds ownership: 47.77%50.36% (+2.6%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $441K

Holders
80
Holders Change
+7
Holders Change %
+9.59%
% of All Funds
1.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
28
Reduced
21
Closed
4
Calls
Puts
$441K
Net Calls
-$441K
Net Calls Change
-$441K

BLFS Hedge Fund Activity: Q3 2019 in Review

80 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q3 2019, worth a combined $170M — up 13% from $150M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BLFS positions and 4 closed out — a net gain of 8 holders — while 28 added to existing stakes and 21 trimmed.

The largest buyer was Park West Asset Management, adding an estimated $8.36M. The largest seller was Sandler Capital Management, cutting an estimated $4.5M.

  • 80 institutional investors held BioLife Solutions (BLFS) as of Q3 2019, up from 73 in Q2 2019.
  • Funds reported $170M of BioLife Solutions stock for Q3 2019, up 13% quarter-over-quarter.
  • 12 funds opened new BioLife Solutions positions in Q3 2019 and 4 closed out, a net change of +8 holders.
  • The largest BioLife Solutions buyer in Q3 2019 was Park West Asset Management, an estimated $8.36M added.
  • The largest BioLife Solutions seller in Q3 2019 was Sandler Capital Management, an estimated $4.5M sold.

Based on aggregated 13F filings for Q3 2019.